Abstract:Importance: Accumulating evidence indicates that higher blood pressure (BP) variability from one physician office visit to the next (hereafter referred to as visit-to-visit BP variability) is associated with poor outcomes. Short-term measurement (throughout 1 year) of visit-to-visit BP variability in high-risk older patients may help identify patients at increased risk of death.Objective: To evaluate whether short-term visit-to-visit BP variability is associated with increased long-term mortality risk.Design, Setting, and Participants: The US cohort of the International Verapamil SR-Trandolapril Study (INVEST), a randomized clinical trial of 16 688 patients aged 50 years or older with hypertension and coronary artery disease, was conducted between September 2, 1997, and December 15, 2000, with in-trial follow-up through February 14, 2003. The study evaluated a calcium antagonist (sustained-release verapamil plus trandolapril) vs β-blocker (atenolol plus hydrochlorothiazide) treatment strategy. Blood pressure measurement visits were scheduled every 6 weeks for the first 6 months and biannually thereafter. Statistical analysis was performed from September 2, 1997, to May 1, 2014.Exposures: Visit-to-visit systolic BP (SBP) and diastolic BP variability during the first year of enrollment using 4 different BP variability measures: standard deviation, coefficient of variation, average real variability, and variability independent of the mean.Main Outcomes and Measures: All-cause death, assessed via the US National Death Index, beginning after the exposure assessment period through May 1, 2014.Results: For the present post hoc analysis, long-term mortality data were available on 16 688 patients (9001 women [54%]; mean [SD] age, 66.5 [9.9] years; 45% White patients, 16% Black patients, and 37% Hispanic patients). During a mean (SD) follow-up of 10.9 (4.2) years, 5058 patients (30%) died. All 4 variability measures for SBP were significantly associated with long-term mortality after adjustment for baseline demographic characteristics and comorbidities. After comparison of lowest vs highest variability measure quintiles, the magnitude of the association with death remained statistically significant even after adjustment for baseline demographic characteristics and comorbidities (average real variability: adjusted hazard ratio [aHR], 1.18; 95% CI, 1.08-1.30; standard deviation: aHR, 1.14; 95% CI, 1.04-1.24; coefficient of variation: aHR, 1.15; 95% CI, 1.06-1.26; variability independent of the mean: aHR, 1.15; 95% CI, 1.05-1.25). The signal was stronger in women compared with men. Associations of diastolic BP variability measures with death were weaker than for SBP and were not significant after adjustment.Conclusions and Relevance: This study suggests that, in a large population of older patients with hypertension and coronary artery disease, short-term visit-to-visit SBP variability was associated with excess long-term mortality, especially for women. Efforts to identify and minimize visit-to-visit SBP variability may be important in reducing excess mortality later in life.Trial Registration: ClinicalTrials.gov Identifier: NCT00133692.

Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients.

Correlation Between Visit-to-visit and Short-Term Blood Pressure Variability Calculated Using Different Methods and Glomerular Filtration Rate

Prognostic Value of Visit-to-visit Systolic Blood Pressure Variability Related to Diabetic Kidney Disease among Patients with Type 2 Diabetes.

Association of Visit-to-Visit Variability of Blood Pressure with Cardiovascular Disease among Type 2 Diabetes Mellitus Patients: A Cohort Study

Visit-to-Visit Blood Pressure Variability and Mortality and Cardiovascular Outcomes Among Older Adults: The Health, Aging, and Body Composition Study

Predictive value of within-visit and visit-to-visit blood pressure variability for all-cause mortality: the Minhang Study

Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease

Association between within-visit blood pressure variability, stroke, coronary heart disease, and cardiovascular mortality

Association of Systolic Blood Pressure Variability with Mortality, Coronary Heart Disease, Stroke, and Renal Disease.

Visit-To-Visit Office Blood Pressure Variability Combined With Framingham Risk Score To Predict All-Cause Mortality: A Post Hoc Analysis Of The Systolic Blood Pressure Intervention Trial

China Stroke Primary Prevention Trial: Visit-to-Visit Systolic Blood Pressure Variability Is an Independent Predictor of Primary Stroke in Hypertensive Patients.

Prognostic Value of Short-Term Blood Pressure Variability over 24 H in 8938 Subjects from 11 Populations

Visit-to-Visit Blood Pressure Variability and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction

Higher Long‐Term Visit‐to‐Visit Blood Pressure Variability Is Associated With Severe Cerebral Small Vessel Disease in the General Population

Relation of recurrent stroke with visit-to-visit variability in systolic blood pressure

Visit‑to‑visit Blood Pressure Variability is Associated with Arterial Stiffness in Chinese Adults: A Prospective Analysis

The Association Between Visit-to-Visit Variability of Blood Pressure and the Risk of Metabolic Syndrome: the Moderating Effect of Weight

Visit-to-visit systolic blood pressure variability in patients with ST-elevation myocardial infarction predicts long-term cardiovascular outcomes

Prognostic Value of Reading-to-reading Blood Pressure Variability over 24 Hours in 8938 Subjects from 11 Populations.

Prognostic Relevance of Short-Term Blood Pressure Variability. The Spanish ABPM Registry

Visit-to-visit blood pressure variability and risk of chronic kidney disease: A systematic review and meta-analyses